Naloxegol
Back to searchMolecule Structure
Scientific Name
Naloxegol
Description of the Drug
Naloxegol is a peripherally-selective opioid antagonist used to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09049
http://www.drugbank.ca/drugs/DB09049
Brand Name(s)
Moventig
Company Owner(s)
Redhill Biopharma Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Mu opioid receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL233 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL19433066 | ||
| DrugBank | DB09049 | ||
| PubChem | 56959087 | ||
| EPA CompTox Dashboard | DTXSID80234684 | ||
| DrugCentral | 4832 | ||
| ChemicalBook | CB32614743 | ||
| Guide to Pharmacology | 7539 | ||
| rxnorm | NALOXEGOL OXALATE | NALOXEGOL | MOVANTIK |
| ChEBI | 82975 | ||
| ZINC | ZINC000095564694 |
